A primary goal of the PNH Foundation is to fund urgently needed medical research into finding new treatments, and ultimately a cure, for PNH disease. The PNH Foundation is a patient-partner of the Aplastic Anemia Aplastic Anemia: (ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell count is low. Most… & MDS International Foundation.
AAMDSIF PNH Research and Support Foundation
Grant Recipient(s)
| Research Title | Grant Year | |
|---|---|---|
| Sushant Kumar, PhD | The mechanisms of immune evasion by PNH clones in aplastic anemia | 2022 |
| Anastasios Karadimitris, MD, PhD | CD1d-restricted, GPI-specific T cells in paroxysmal nocturnal hemoglobinuria | 2015 |
| Chao-Yie Yang, MD, PhD | Discovery of small molecule complement inhibitors as the treatment for PNH | 2014 |
| Patrizia Ricci, PhD | Small peptide C3-inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria: moving towards the bedside | 2014 |
| Hideki Makishima, MD, PhD | Clonal Architecture in PNH: Somatic genetic defects facilitating clonal expansion | 2013 |
| Jeffrey Pu, MD, PhD | Relevance of PIG-A mutations in acquired bone marrow failure diseases | 2012 |
| David Araten, MD | Secondary mutations and thrombosis in PNH | 2012 |
| Keith McCrae, MD | Circulating microparticles in PNH | 2011 |
| Regis Peffault deLatour, MD, PhD | The role of Unfolded Protein Response in PNH | 2009 |